Cite
HARVARD Citation
Esbenshade, A. et al. (2017). A Phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high‐risk medulloblastoma (protocol POG 9631): A report from the Children's Oncology Group. Pediatric blood & cancer. 64 (6), p. n/a. [Online].